Please try another search
For the nine months ended 30 September 2019, Genomic Health, Inc. revenues increased 16% to $337.3M. Net income increased from $16.8M to $47.7M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Interest income increase from $1.5M to $3.9M (income). Basic Earnings per Share excluding Extraordinary Items increased from $0.47 to $1.28.
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Revenue | 114.36 | 114.14 | 108.77 | 104.61 |
Gross Profit | 95.65 | 96.47 | 91.76 | 88.92 |
Operating Income | 19.05 | 15.5 | 11.54 | 9.43 |
Net Income | 18.69 | 15.99 | 13 | 8.91 |
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Assets | 460.41 | 426.16 | 392.79 | 334.37 |
Total Liabilities | 111.04 | 108.94 | 104.91 | 64.21 |
Total Equity | 349.37 | 317.22 | 287.88 | 270.16 |
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Period Length: | 9 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 66.88 | 34.71 | -3.67 | 76.56 |
Cash From Investing Activities | -68.37 | -10.33 | 45.22 | -81.11 |
Cash From Financing Activities | 11.8 | 4.88 | -1.8 | 20.75 |
Net Change in Cash | 10.31 | 29.27 | 39.76 | 16.21 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review